Navigation Links
Bionovo to Present at the Cambria Capital Investor Meeting
Date:3/26/2008

w.cambriacapital.com" target="_new">http://www.cambriacapital.com

About Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.

Forward Looking Statements

This release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Bionovo Announces Closing of Public Offering of Common Stock
2. Bionovo Describes a New Class of Therapeutic Compounds
3. Bionovo Announces 2007 Financial Results and Highlights
4. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
5. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
6. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
7. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
9. AtriCure to Present at Roth Capital Partners 2007 New York Conference
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. MDS to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... HealthDay Reporter MONDAY, ... cholesterol down to extremely low levels with a combination ... in high-risk patients with clogged arteries, a new study ... when taking Vytorin, a drug that combines a cholesterol-lowering ... said principal investigator Dr. Christopher Cannon, a cardiologist at ...
(Date:11/18/2014)... 18, 2014 (HealthDay News) -- Cocaine users can have ... to detect, which can put them at increased risk ... Researchers in Chicago compared heart imaging test results ... use the illegal drug. Those using cocaine showed ... blood vessels, which were considered significant when compared to ...
(Date:11/18/2014)... 18, 2014 Global Partnership ... the telehealth platform to bring quality healthcare to ... passion, GPT created Global Partnership for TeleHealth Missions ... existing telehealth network. GPTM focuses specifically on ... and disaster relief organizations. , Michael ...
(Date:11/18/2014)... (PRWEB) November 18, 2014 A+ ... for pharmaceutical, nutraceutical, dietary supplements and more, announced ... NSF International’s Good Manufacturing Practices (GMP) Registration for ... GMP registration from NSF International verifies the A+ ... and quality compliance requirements of its clients by ...
(Date:11/18/2014)... HealthDay Reporter MONDAY, Nov. 17, 2014 ... abusive head trauma before the age of 5 will die ... In addition, among those who survive severe injuries, quality ... Abusive head trauma includes shaken baby syndrome, in which ... according to background information in the study. In the ...
Breaking Medicine News(10 mins):Health News:Cholesterol Drug Vytorin Linked to Reduced Heart Attack Risk 2Health News:Cholesterol Drug Vytorin Linked to Reduced Heart Attack Risk 3Health News:Cocaine Can Cause Heart Problems: Study 2Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 4
... , , SUNNYVALE, ... a global leader in the field of radiosurgery today announced that ... Robotic Radiosurgery System at Hopital Notre-Dame du CHUM, in Montreal, Canada. ... the CHUM,s Radio-oncology Department is a definite asset for our treatment ...
... , MOUNTAIN VIEW, Calif., Sept. 16 Recognized for ... Graham, will provide insight on health care reform at the Silicon ... a.m. at the Rotary Summit Center. , , With ... health care reform debate. El Camino Hospital, a non-profit community hospital that ...
... PARK, N.C., Sept. 16 GlaxoSmithKline (NYSE: GSK ) ... for patients who are unemployed, uninsured or struggling to make ends ... its patient assistance program, Bridges to Access, by offering two ways ... by telephone with the help of a healthcare advocate such as ...
... , WASHINGTON, Sept. 16 The U.S. ... to include a boxed warning regarding the injectable form of the ... will highlight the risk of serious tissue injury when this drug ... to the new boxed warning for this product, which is used ...
... , , FALLS CHURCH, ... recognized and innovative leader in digital pathology solutions, has been ... as the vendor to implement its digital pathology informatics vision. ... (Picture Archive and Communication System) solution to meet their operational ...
... , , , SEBASTOPOL, ... and exotic ingredients grows, rainforest-grown yerba mate is ... hit the market. , , (Photo: ... , a pioneer and leader in the yerba mate beverage category, ...
Cached Medicine News:Health News:First CyberKnife System Installed in Canada 2Health News:First CyberKnife System Installed in Canada 3Health News:First CyberKnife System Installed in Canada 4Health News:El Camino Hospital Provides Local Perspective on Health Care Reform and Innovation at Silicon Valley Healthcare CEO Summit 2Health News:GSK Makes it Easier for Unemployed, Uninsured to Get Free Medicines 2Health News:GSK Makes it Easier for Unemployed, Uninsured to Get Free Medicines 3Health News:FDA Requires Boxed Warning for Promethazine Hydrochloride Injection 2Health News:Apollo PACS, Inc. Selected by Henry Ford Health System for Its Digital Pathology Solution 2Health News:Apollo PACS, Inc. Selected by Henry Ford Health System for Its Digital Pathology Solution 3Health News:Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 2Health News:Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 3
(Date:11/18/2014)... , November 18, 2014 Investor-Edge ... EXEL ), Geron Corporation (NASDAQ: GERN ... Biopharma Inc. (NASDAQ: GALE ), and XOMA Corporation ... companies can be accessed at: http://investor-edge.com/register . ... a mixed note as the Dow Jones Industrial Average finished ...
(Date:11/18/2014)... Nov. 18, 2014 Pressure BioSciences, Inc. ... the installation of its first two Barozyme HT-48 ... potential sale. One system was placed in the ... Georgetown University while the other was placed in ... both settings, the Company believes the new systems ...
(Date:11/18/2014)... , November 18, 2014 ... knowledge of the overall new requirements of application dossiers ... China but also provides the guidance of ... for your products entry into the Chinese medical device ... medical device market is one of segment market of ...
Breaking Medicine Technology:Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5Pressure BioSciences Ships First Two Barozyme HT48 Systems 2Pressure BioSciences Ships First Two Barozyme HT48 Systems 3Pressure BioSciences Ships First Two Barozyme HT48 Systems 4Pressure BioSciences Ships First Two Barozyme HT48 Systems 5Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 2Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 3Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 4Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 5Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 6Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 7Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation in China (2014 Edition) 8
... Ariz.--(BUSINESS WIRE)--Jun 27, 2007 - Annals of,Internal Medicine ... on the impact of genistein on bone loss. ... Metabolism in Osteopenic,Postmenopausal Women-A Randomized Trial," appears in ... safety and efficacy of,genistein for the dietary management ...
... & CEO of the Lupus,Foundation of America, Inc., ... of America, Inc. and more than 1.5 million ... of the Phase,III clinical trials for CellCept(R), a ... Aspreva Pharmaceutical,Company. Development of new treatments for lupus ...
Cached Medicine Technology:New Proof of Genistein's Efficacy and Safety for Osteopenia and,Osteoporosis Published in Annals of Internal Medicine 2New Proof of Genistein's Efficacy and Safety for Osteopenia and,Osteoporosis Published in Annals of Internal Medicine 3Lupus Foundation of America Statement on Results for Clinical Study,of CellCept Released by Aspreva Pharmaceutical Company 2
The multi-access blanket offers access to any part of the patient's body while providing full patient coverage....
The chest access blanket is designed specifically for the thoracic surgery patient....
The adult blanket provides full coverage for patients of all sizes. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also reduces ...
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
Medicine Products: